Rhenium and technetium not only share the same group in the periodic table, but also have some common history relating to how they were — or indeed weren't — discovered. Eric Scerri explains.

Plus Therapeutics presents ReSPECT-LM phase 1 trial data for breast cancer patients with leptomeningeal metastases: Austin, Texas Friday, December 20, 2024, 18:00 Hrs [IST] Plus T ...

This MSA secures a reliable supply of cGMP Re-186, the radioisotope used in Plus Therapeutics’ lead radiotherapeutic candidate Rhenium (186Re) Obisbemeda. “This continuing agreement with Telix ...

Plus Therapeutics (PSTV) presented data updating the progress of its ReSPECT-LM Phase 1 clinical trial of Rhenium Obisbemeda in leptomeningeal disease with a specific focus on breast cancer patients.

Obisbemeda shows a favorable response rate and median overall survival in leptomeningeal metastases (LM) patients Achieves up to 8x absorbed radiation dose to the CNS subarachnoid space vs. standard ...